Evotec SE EVO
NASDAQ EVO
$1.48 +0.06 (+4.22%)
As of: Oct 20, 2026 · 1:03 PM EDT

Evotec SE (EVO) Common Equity (2009 - 2026)

Updated

Evotec SE (EVO) recorded Common Equity of $773.64 million in the quarter ended Jun 30, 2026, down 19.2% from $957.4 million a year earlier and down 5.5% from the prior quarter.

Analysis

Evotec SE (EVO) Common Equity (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Evotec SE reported Common Equity of $919.33 million, down 10.8% from the prior year.

  • Annual Common Equity has declined for four straight years, though with a five-year compound annual growth rate of 2.1% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Common Equity came in at $1.03 billion in the year ended Dec 31, 2024 (-14.9%), $1.21 billion in the year ended Dec 31, 2023 (-3.2%), $1.25 billion in the year ended Dec 31, 2022 (-23.3%) and $1.63 billion in the year ended Dec 31, 2021 (+97.1%).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Common Equity since the quarter ended Dec 31, 2019.
  • On a year-over-year basis, Common Equity has declined for four consecutive quarters, with an average decline of 13.7% over the last five quarters.
  • Peak year-over-year performance for Common Equity in the last five years was growth of 82.5% in the quarter ended Dec 31, 2021, against a decline of 23.1% in the quarter ended Dec 31, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $819.08 million (quarter ended Mar 31, 2026), $947.19 million (quarter ended Dec 31, 2025) and $935.4 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Iqvia Holdings 44.63 Bn 36.33 Bn 1.44 Bn 6.30 Bn
2 Medpace Holdings 17.74 Bn 15.81 Bn 201.64 Mn 433.86 Mn
3 Charles River Laboratories International 15.08 Bn 14.28 Bn 363.37 Mn 2.85 Bn
4 Icon 13.82 Bn 10.93 Bn 479.29 Mn 9.38 Bn
5 Fortrea Holdings 2.21 Bn 1.59 Bn 139.20 Mn 524.20 Mn
6 Ginkgo Bioworks Holdings 629.64 Mn -132.45 Mn 18.44 Mn 420.28 Mn
7 Evotec SE 525.63 Mn -1.09 Bn - 760.23 Mn
8 Champions Oncology 66.43 Mn 41.52 Mn 7.70 Mn 4.46 Mn
9 MindWalk Holdings 61.22 Mn 24.88 Mn 1.61 Mn 4.93 Mn
10 Natural Alternatives International 6.93 Mn -21.15 Mn 1.73 Mn 49.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 760.23 Mn
Mar 31, 2026 801.76 Mn
Dec 31, 2025 955.88 Mn
Sep 30, 2025 938.68 Mn
Jun 30, 2025 991.89 Mn
Mar 31, 2025 987.29 Mn
Dec 31, 2024 991.21 Mn
Sep 30, 2024 1.08 Bn
Dec 31, 2023 1.24 Bn
Jun 30, 2023 1.28 Bn
Dec 31, 2022 1.27 Bn
Sep 30, 2022 1.21 Bn
Mar 31, 2022 1.46 Bn
Dec 31, 2021 1.56 Bn
Sep 30, 2021 1.15 Bn
Dec 31, 2020 891.07 Mn
Dec 31, 2019 536.16 Mn
Sep 30, 2010 179.92 Mn
Jun 30, 2010 144.89 Mn
Mar 31, 2010 152,047.82
API Access

Evotec SE Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=EVO&period=max&api_key=YOUR_API_KEY